Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
| ▸ | GJA1 | P17302 | 1/20 | 0.43 |
| ▸ | GJB2 | P29033 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CDK1 | P06493 | 1/20 | 0.43 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 3/20 | 0.41 |
| ▸ | IGF2R | P11717 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactulose SCHEMBL180915 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL18470690 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL18912 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL15942980 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL11892653 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL12787176 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL18479188 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL11890264 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL15942982 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL17241809 | 1.00 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170216328-A1 | METHODS AND COMPOSITIONS FOR MICROBIOME ALTERATION | RITTER PHARMACEUTICALS, INC. | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170216328-A1 | METHODS AND COMPOSITIONS FOR MICROBIOME ALTERATION | SI, FABP2, MGAM | MEN1 2427/4885KMT2A 3394/4885LGALS8 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.